| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22908 [W. Y., J-P. W., R. J. S.], and Department of Pathology, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania 17033 [C. J. H., L. M. D.]
The high concentrations of estradiol (E2) found in breast tumors of postmenopausal women could be the result of enhanced uptake from plasma or in situ aromatization of androgens to estrogens. To test the relative importance of these two mechanisms, a model system allowing precise distinction between each is required. Such a model was established using aromatase (A+)- and sham (A-)-transfected MCF-7 cells inoculated into ovariectomized (OVX) nude mice. To validate the model, the confounding effect of peripheral aromatization was first excluded experimentally. A- cells were inoculated into OVX mice as homoimplants (A- cells on both flanks) or heteroimplants (A- cells on one flank and A+ cells on the other), and growth of A- cells in response to exogenous aromatase substrate, androstenedione (
4A), was evaluated. A- cells did not grow in either group during the 8 weeks of observation, indicating the lack of peripheral aromatization in OVX mice. The biological effects of in situ aromatization were then directly examined. We found that A+ cells in the heteroimplant group grew rapidly, and that the average weight of A+ tumor was 7.6-fold larger and tissue E2 concentration was 3–4-fold higher than A- tumors grown in the same animals. These results demonstrate that in situ aromatization rather than uptake can be a determinant of tumor E2 content and growth stimulation.
An additional experiment was then designed to evaluate the relative importance of in situ synthesis versus uptake under conditions reflecting postmenopausal physiology. Groups of OVX mice bearing A+ cells received E2 Silastic implants to clamp plasma levels at 5, 7, 10, and 20 pg/ml or 4A by injection. The highest tumor E2 concentration and growth rate were found in the group receiving 4A. E2 delivered by Silastic implants always produced lower tissue E2 levels and tumor growth rates than resulted from in situ synthesis. These data provide direct evidence that under physiological conditions reflecting those in postmenopausal women, in situ aromatization in breast tumor makes a major contribution to tissue E2 content.
As further validation that our experimental paradigm models the postmenopausal state, we studied OVX animals not given 4A as substrate. A+ cells also grew under these conditions, and the aromatase inhibitor 4-hydroxyandrostenedione reduced both tumor E2 level and growth rate, providing additional evidence of the importance of in situ synthesis. These studies provide the first direct evidence that in situ synthesis of E2 in breast tumors, as opposed to peripheral aromatization and uptake from plasma, can enhance tissue E2 levels and stimulate tumor growth.
1 Supported by NIH Grant CA65622.
2 To whom requests for reprints should be addressed, at Department of Internal Medicine, P. O. Box 513, Health Sciences Center, University of Virginia, Charlottesville, VA 22908.
Received 9/15/97. Accepted 1/ 5/98.
This article has been cited by other articles:
|
|
 |
|
  S. Masri, S. Phung, X. Wang, X. Wu, Y.-C. Yuan, L. Wagman, and S. Chen Genome-Wide Analysis of Aromatase Inhibitor-Resistant, Tamoxifen-Resistant, and Long-Term Estrogen-Deprived Cells Reveals a Role for Estrogen Receptor Cancer Res., June 15, 2008; 68(12): 4910 - 4918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Bukulmez, D. B. Hardy, B. R. Carr, R. A. Word, and C. R. Mendelson Inflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis Endocrinology, March 1, 2008; 149(3): 1190 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lu, D. Chen, Z. Lin, S. Reierstad, A. M. Trauernicht, T. G. Boyer, and S. E. Bulun BRCA1 Negatively Regulates the Cancer-Associated Aromatase Promoters I.3 and II in Breast Adipose Fibroblasts and Malignant Epithelial Cells J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4514 - 4519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Husen, K. Huhtinen, T. Saloniemi, J. Messinger, H. H. Thole, and M. Poutanen Human Hydroxysteroid (17-{beta}) Dehydrogenase 1 Expression Enhances Estrogen Sensitivity of MCF-7 Breast Cancer Cell Xenografts Endocrinology, November 1, 2006; 147(11): 5333 - 5339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Galmiche, N. Richard, S. Corvaisier, and M.-L. Kottler The Expression of Aromatase in Gonadotropes Is Regulated by Estradiol and Gonadotropin-Releasing Hormone in a Manner that Differs from the Regulation of Luteinizing Hormone Endocrinology, September 1, 2006; 147(9): 4234 - 4244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Toyama, Z. Zhang, H. Iwase, H. Yamashita, Y. Ando, M. Hamaguchi, M. Mizutani, N. Kondo, T. Fujita, Y. Fujii, et al. Low Expression of the Snail Gene is a Good Prognostic Factor in Node-Negative Invasive Ductal Carcinomas Jpn. J. Clin. Oncol., June 1, 2006; 36(6): 357 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Deb, J. Zhou, S. A. Amin, A. G. Imir, M. B. Yilmaz, Z. Lin, and S. E. Bulun A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters I.3 and II by Disrupting a Transcriptional Complex in Breast Adipose Fibroblasts J. Biol. Chem., February 3, 2006; 281(5): 2585 - 2597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Shin, T. Miller, and C. L. Arteaga ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors Clin. Cancer Res., February 1, 2006; 12(3): 1008s - 1012s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Bouchard, H. Taniguchi, and R. S. Viger Protein Kinase A-Dependent Synergism between GATA Factors and the Nuclear Receptor, Liver Receptor Homolog-1, Regulates Human Aromatase (CYP19) PII Promoter Activity in Breast Cancer Cells Endocrinology, November 1, 2005; 146(11): 4905 - 4916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yue, J.-P. Wang, Y. Li, W. P. Bocchinfuso, K. S. Korach, P. D. Devanesan, E. Rogan, E. Cavalieri, and R. J. Santen Tamoxifen versus Aromatase Inhibitors for Breast Cancer Prevention Clin. Cancer Res., January 15, 2005; 11(2): 925s - 930s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Fan, T. Yanase, H. Morinaga, Y.-M. Mu, M. Nomura, T. Okabe, K. Goto, N. Harada, and H. Nawata Activation of Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Inhibits Aromatase Transcription via Nuclear Factor-{kappa}B Endocrinology, January 1, 2005; 146(1): 85 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Eng, J. Ye, D. Williams, S. Phung, R. E. Moore, M. K. Young, U. Gruntmanis, G. Braunstein, and S. Chen Suppression of Estrogen Biosynthesis by Procyanidin Dimers in Red Wine and Grape Seeds Cancer Res., December 1, 2003; 63(23): 8516 - 8522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Haiman, D. O. Stram, M. C. Pike, L. N. Kolonel, N. P. Burtt, D. Altshuler, J. Hirschhorn, and B. E. Henderson A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort Hum. Mol. Genet., October 16, 2003; 12(20): 2679 - 2692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sebastian, K. Takayama, M. Shozu, and S. E. Bulun Cloning and Characterization of a Novel Endothelial Promoter of the Human CYP19 (Aromatase P450) Gene that Is Up-Regulated in Breast Cancer Tissue Mol. Endocrinol., October 1, 2002; 16(10): 2243 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. M. Castagnetta, O. M. Granata, A. Traina, B. Ravazzolo, M. Amoroso, M. Miele, V. Bellavia, B. Agostara, and G. Carruba Tissue Content of Hydroxyestrogens in Relation to Survival of Breast Cancer Patients Clin. Cancer Res., October 1, 2002; 8(10): 3146 - 3155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Rubin, J. H. Duong, C. D. Clyne, C. J. Speed, Y. Murata, C. Gong, and E. R. Simpson Ligands for the Peroxisomal Proliferator-Activated Receptor {gamma} and the Retinoid X Receptor Inhibit Aromatase Cytochrome P450 (CYP19) Expression Mediated by Promoter II in Human Breast Adipose Endocrinology, August 1, 2002; 143(8): 2863 - 2871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Cohen, J. R. Johnson, N. Li, G. Chen, and R. Pazdur Approval Summary: Letrozole in the Treatment of Postmenopausal Women with Advanced Breast Cancer Clin. Cancer Res., March 1, 2002; 8(3): 665 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Haiman, M. Brown, S. E. Hankinson, D. Spiegelman, G. A. Colditz, W. C. Willett, P. W. Kantoff, and D. J. Hunter The Androgen Receptor CAG Repeat Polymorphism and Risk of Breast Cancer in the Nurses' Health Study Cancer Res., February 1, 2002; 62(4): 1045 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gunnarsson, B. M. Olsson, and O. Stal Abnormal Expression of 17{beta}-Hydroxysteroid Dehydrogenases in Breast Cancer Predicts Late Recurrence Cancer Res., December 1, 2001; 61(23): 8448 - 8451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J Grube, E. T. Eng, Y.-C. Kao, A. Kwon, and S. Chen White Button Mushroom Phytochemicals Inhibit Aromatase Activity and Breast Cancer Cell Proliferation J. Nutr., December 1, 2001; 131(12): 3288 - 3293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-W. Huang, I. Pineau, H.-J. Chang, A. Azzi, V. Bellemare, S. Laberge, and S.-X. Lin Critical Residues for the Specificity of Cofactors and Substrates in Human Estrogenic 17{beta}-Hydroxysteroid Dehydrogenase 1: Variants Designed from the Three-Dimensional Structure of the Enzyme Mol. Endocrinol., November 1, 2001; 15(11): 2010 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kirma, K. Gill, U. Mandava, and R. R. Tekmal Overexpression of Aromatase Leads to Hyperplasia and Changes in the Expression of Genes Involved in Apoptosis, Cell Cycle, Growth, and Tumor Suppressor Functions in the Mammary Glands of Transgenic Mice Cancer Res., March 1, 2001; 61(5): 1910 - 1918. [Abstract] [Full Text]
|
|
|
|
|
|
J. Zhou, B. Gurates, S. Yang, S. Sebastian, and S. E. Bulun Malignant Breast Epithelial Cells Stimulate Aromatase Expression via Promoter II in Human Adipose Fibroblasts: An Epithelial-Stromal Interaction in Breast Tumors Mediated by CCAAT/Enhancer Binding Protein {beta} Cancer Res., March 1, 2001; 61(5): 2328 - 2334. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Clemons and P. Goss Estrogen and the Risk of Breast Cancer N. Engl. J. Med., January 25, 2001; 344(4): 276 - 285. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Cavalieri, K. Frenkel, J. G. Liehr, E. Rogan, and D. Roy Chapter 4: Estrogens as Endogenous Genotoxic Agents--DNA Adducts and Mutations J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 75 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Jefcoate, J. G. Liehr, R. J. Santen, T. R. Sutter, J. D. Yager, W. Yue, S. J. Santner, R. Tekmal, L. Demers, R. Pauley, et al. Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 95 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Liehr Is Estradiol a Genotoxic Mutagenic Carcinogen? Endocr. Rev., February 1, 2000; 21(1): 40 - 54. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Pauley, S. J. Santner, L. R. Tait, R. K. Bright, and R. J. Santen Regulated CYP19 Aromatase Transcription in Breast Stromal Fibroblasts J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 837 - 846. [Abstract] [Full Text]
|
|
|
|
|
|
W.-S. Shim, M. Conaway, S. Masamura, W. Yue, J.-P. Wang, R. Kumar, and R. J. Santen Estradiol Hypersensitivity and Mitogen-Activated Protein Kinase Expression in Long-Term Estrogen Deprived Human Breast Cancer Cells in Vivo Endocrinology, January 1, 2000; 141(1): 396 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sasano and N. Harada Intratumoral Aromatase in Human Breast, Endometrial, and Ovarian Malignancies Endocr. Rev., October 1, 1998; 19(5): 593 - 607. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
